期刊文献+

2型糖尿病患者同型半胱氨酸与凝血指标结果分析

The results analysis of homocysteine and blood coagulation index in patients with type 2 diabetes
下载PDF
导出
摘要 目的:回顾性分析2型糖尿病患者糖化血红蛋白(HbA1c)、同型半胱氨酸(Hcy)、凝血指标的关系。方法:152例2型糖尿病患者以糖化血红蛋白6.5%为临界,分为血糖控制良好组(HbA1c〈6.5%)及血糖控制不良组(HbA1c〉6.5%),同时,选取30例健康体检者为正常对照组,比较各组间同型半胱氨酸(Hcy)及凝血指标(PT, APTT ,TT, FIB-C)的差异,并分析各指标与糖化血红蛋白水平的相关性。结果:与对照组比较,糖尿病控制良好组 Hcy显著增高(P〈0.05),凝血指标变化不具有统计学意义;糖尿病控制不良组较其他两组,Hcy显著增高(P〈0.01), APTT显著下降(P〈0.05),FIB-C显著上升(P〈0.05);糖尿病患者同型半胱氨酸(Hcy)水平、APTT缩短与糖化血红蛋白(HbA1c)呈正相关。结论:血浆Hcy水平及凝血功能异常可能是导致糖尿病并发症的危险因素。 Objective:To observe relational changes of plasma glycated hemoglobin (HbA1c),homocysteine(Hcy) and coagulation in patients with type 2 diabetes.Methods:152 cases of patients with type 2 diabetes were divided into good glycemic control group(HbA1c〈6.5% ) and poor glycemic control group (HbA1c〉6.5%), and 30 cases of normal controls were collected. Plasma glycated hemoglobin (HbA1c), homocysteine(Hcy) ,coagulation parameters (PT, APTT, TT, FIB-C) were measured and compared among the three groups, in addition, the correlations between Hcy ,PT, APTT, TT, FIB-C and HbA1c were analyzed. Results: Hcy of good glycemic control group was higher than normal group(P〈 0.05), while the changes of PT, APTT, TT, FIB - C were not obvious. Compared with good glycemic control group and normal control group, poor glycemic control group showed significantly higher Hcy (P〈 0.01) ,shorter APTT(P〈 0.05) and elevated FIB-C(P〈 0.05). The result displayed the positive correlations between Hcy ,APTT shortening and HbA1c of the patients with type 2 diabetes.Conclusions:Plasma Hcy levels and abnormal coagulation could be the risk factor of diabetes complications.
出处 《医学检验与临床》 2015年第3期13-15,共3页 Medical Laboratory Science and Clinics
关键词 2型糖尿病 同型半胱氨酸 糖化血红蛋白 凝血 Type 2 diabete Homocysteine HbAlc Coagulation
  • 相关文献

参考文献14

  • 1Clement S, Braithwaite SS, Magee MF, et al. Management of diabetes and hyperglycemia in hospitals[J]. Diabetes Care, 2004;27:553 - 591.
  • 2Lemkes BA, Hermanides J, Devries JH, et al. Hyperglycemia: a prothrombotic factor?[J] . Thromb Haemost, 2010;8:1663 - 1669.
  • 3American Diabetes association. Stadards of medical care in diabetes[J]. Diabetes Care, 2004, 27(Supp 1):S15-35.
  • 4任娜,赵威,赵丽菲,邱广斌.糖化血红蛋白与活化部分凝血活酶时间的相关性研究[J].检验医学与临床,2011,8(8):907-908. 被引量:2
  • 5Lippi G, Franchini M, Targher G, et al. Epidemiological association between fasting plasma glucose and shortened APTT[J]. Clin Biochem, 2009;42:118- 120.
  • 6Sapkota B1, Shrestha SK, Poudel S.Association of activated partial thromboplastin time and fibrinogen level in patients with type Ildiabetes mellitus[J]. BMC RES NOTES, 2013 Nov 25;6:485. doi: 10.1186/1756-0500-6-485.
  • 7吕志刚,汤巧.老年2型糖尿病患者凝血指标变化探讨[J].江苏大学学报(医学版),2002,12(3):252-253. 被引量:4
  • 8陆菊明,谷伟军.同型半胱氨酸与糖尿病及其血管并发症的关系[J].中华老年医学杂志,2005,24(6):472-472. 被引量:16
  • 9Munshi MN, Stone A, Fink L,et al. Hyperhomocysteinemia following a methionine load in patients with non-insulin- dependent diabetes mellitue and macrovascular disease[J]. Metabolism, 1996,45:133-135.
  • 10Hofmann MA, Kohl B, Zumbach MS, et al. Hyperhomoc ysteinemia and endothelial dysfunction in IDDM[J]. Diabetes Care, 1998,21:841-848.

二级参考文献29

  • 1Cleeman JI.Executive summary of the third report of the National Cholesterol Education program(NCER) expert panel on detection,evaluation,and treatment of high blood Cholesterol in adults (Adult treatment Panel Ⅲ)[J].JAMA,2001,285(3):2486-2497.
  • 2American Diabetes association.Stadards of medical care in diabetes[J].Diabetes Care,2004,27(Supp 1):S15-35.
  • 3Tripodi A,Chantarangkul V,Martinelli I,et al.A shortened activated partial thromboplastin time isassociated with therisk of venous thromboe mbolism[J].Blood,2004,104(12):3631-3634.
  • 4Hron G,Eichinger S,Weltermann A,et al.Prediction of recurrent venous thromboembolism by the activated partial thromboplastin time[J].J Thromb Haemost,2006,4(4):752-756.
  • 5Lippi G,Franchini M,Targher G,et al.Favaloro.Epidemiological association between fasting plasma glucose and shortened APTT[J].Clin Biochemistry,2009,42(1-2):118-120.
  • 6Grant PJ.Diabetes mellitus as a prothrombotic condition[J].J Intern Med,2007,262(2):157-172.
  • 7陈志坚.糖尿病患者血浆纤维蛋白原和红细胞比积的测定及临床意义[J].广西医科大学学报,2000,17(1).
  • 8Chan P, Pan WH. Coagulation activation in type 2 diabetes mellitus: the higher coronary risk of female diabetic patients[J]. Diabet Med, 1995,12(6) :504 - 507.
  • 9楼定安 单子葭.高胆固醇血症低密度脂蛋白浸润动脉壁的途径[J].中华病理学杂志,1992,21(1):56-56.
  • 10Goldstein DE,Little RR,Lorenz RA,et al.American Diabetes Associa-tion.Tests of glycemia in diabetes[J].Diabetes Care,2003, 26(Suppl1): S106-B.

共引文献68

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部